Peptron, Inc. (087010.KQ)

KRW 98300.0

(-1.99%)

Total Debt Summary of Peptron, Inc.

Peptron, Inc.'s latest annual total debt in 2023 was 9.13 Billion KRW , down -1.01% from previous year.
Peptron, Inc.'s latest quarterly total debt in 2024 Q2 was 9.21 Billion KRW , up 1.11% from previous quarter.
Peptron, Inc. reported annual total debt of 9.22 Billion KRW in 2022, up 0.76% from previous year.
Peptron, Inc. reported annual total debt of 9.15 Billion KRW in 2021, down -0.88% from previous year.
Peptron, Inc. reported quarterly total debt of 9.21 Billion KRW for 2024 Q2, up 1.11% from previous quarter.
Peptron, Inc. reported quarterly total debt of 9.15 Billion KRW for 2023 Q3, down -0.26% from previous quarter.

Annual Total Debt Chart of Peptron, Inc. (2023 - 2012)

Historical Annual Total Debt of Peptron, Inc. (2023 - 2012)

Year	Total Debt	Total Debt Growth
2023	9.13 Billion KRW	-1.01%
2022	9.22 Billion KRW	0.76%
2021	9.15 Billion KRW	-0.88%
2020	9.23 Billion KRW	203.75%
2019	3.04 Billion KRW	-87.27%
2018	23.88 Billion KRW	1094.05%
2017	2 Billion KRW	0.0%
2016	2 Billion KRW	-9.09%
2015	2.2 Billion KRW	-2.94%
2014	2.26 Billion KRW	-71.7%
2013	8 Billion KRW	0.0%
2012	- KRW	0.0%

Year	Total Debt	Total Debt Growth
2024 Q1	9.1 Billion KRW	-0.26%
2024 Q2	9.21 Billion KRW	1.11%
2023 Q3	9.15 Billion KRW	-0.26%
2023 Q1	9.2 Billion KRW	-0.22%
2023 Q2	9.18 Billion KRW	-0.26%
2023 FY	9.13 Billion KRW	-1.01%
2023 Q4	9.13 Billion KRW	-0.27%
2022 Q4	9.22 Billion KRW	-0.26%
2022 Q3	9.24 Billion KRW	-0.12%
2022 Q2	9.26 Billion KRW	1.37%
2022 FY	9.22 Billion KRW	0.76%
2022 Q1	9.13 Billion KRW	-0.22%
2021 Q4	9.15 Billion KRW	-0.27%
2021 FY	9.15 Billion KRW	-0.88%
2021 Q2	9.2 Billion KRW	-0.13%
2021 Q3	9.18 Billion KRW	-0.26%
2021 Q1	9.21 Billion KRW	-74.29%
2020 Q1	29.17 Billion KRW	0.11%
2020 Q4	35.85 Billion KRW	0.53%
2020 Q2	30.33 Billion KRW	3.97%
2020 Q3	35.66 Billion KRW	17.56%
2020 FY	9.23 Billion KRW	203.75%
2019 Q3	20.5 Billion KRW	0.07%
2019 Q2	20.49 Billion KRW	-14.12%
2019 Q1	23.86 Billion KRW	-0.07%
2019 FY	3.04 Billion KRW	-87.27%
2019 Q4	29.14 Billion KRW	42.11%
2018 Q1	19.57 Billion KRW	878.51%
2018 FY	23.88 Billion KRW	1094.05%
2018 Q3	25 Billion KRW	0.0%
2018 Q2	25 Billion KRW	27.76%
2018 Q4	23.88 Billion KRW	-4.49%
2017 Q3	2 Billion KRW	0.0%
2017 Q4	2 Billion KRW	0.0%
2017 FY	2 Billion KRW	0.0%
2017 Q1	2 Billion KRW	0.0%
2017 Q2	2 Billion KRW	0.0%
2016 Q2	2 Billion KRW	-9.09%
2016 Q1	2.2 Billion KRW	0.0%
2016 FY	2 Billion KRW	-9.09%
2016 Q4	2 Billion KRW	0.0%
2016 Q3	2 Billion KRW	0.0%
2015 Q4	2.2 Billion KRW	0.0%
2015 Q2	2.2 Billion KRW	-2.94%
2015 Q1	2.26 Billion KRW	0.0%
2015 FY	2.2 Billion KRW	-2.94%
2015 Q3	2.2 Billion KRW	0.0%
2014 Q1	- KRW	0.0%
2014 FY	2.26 Billion KRW	-71.7%
2013 FY	8 Billion KRW	0.0%
2012 FY	- KRW	0.0%

Peer Total Debt Comparison of Peptron, Inc.

Name	Total Debt	Total Debt Difference
HLB Co., Ltd.	62.7 Billion KRW	85.435%
iNtRON Biotechnology, Inc.	402.9 Million KRW	-2166.759%
BINEX Co., Ltd.	53.5 Billion KRW	82.931%
Bioneer Corporation	44.63 Billion KRW	79.541%
Anterogen.Co.,Ltd.	9.74 Billion KRW	6.236%
MEDIPOST Co., Ltd.	52.33 Billion KRW	82.55%
CrystalGenomics, Inc.	32 Billion USD	71.462%
Helixmith Co., Ltd	20.22 Billion KRW	54.849%
Chabiotech Co.,Ltd.	449.63 Billion KRW	97.969%
Medy-Tox Inc.	82.83 Billion KRW	88.974%
Amicogen, Inc.	149.59 Billion KRW	93.895%
Genexine, Inc.	67.42 Billion KRW	86.455%
HLB Therapeutics Co.,Ltd.	10.02 Billion KRW	8.874%
LegoChem Biosciences, Inc.	12.64 Billion KRW	27.768%
ALTEOGEN Inc.	83.76 Billion KRW	89.097%
PharmaResearch Co., Ltd.	34.3 Billion KRW	73.378%
SillaJen, Inc.	9.69 Billion KRW	5.813%
JETEMA, Co., Ltd.	130.49 Billion KRW	93.001%
OliX Pharmaceuticals,Inc	39.35 Billion KRW	76.795%
Genomictree Inc.	1.83 Billion KRW	-397.803%
MedPacto, Inc.	8.6 Billion KRW	-6.147%
D&D Pharmatech	8.13 Billion KRW	-12.277%
EASY BIO,Inc.	82.27 Billion KRW	88.9%
GI Innovation, Inc.	3.72 Billion KRW	-145.456%